Country: Singapore
Language: English
Source: HSA (Health Sciences Authority)
POLICRESULEN
TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.
G01AX03
90 mg
SUPPOSITORY
POLICRESULEN 90 mg
VAGINAL
Pharmacy Only
Takeda GmbH
ACTIVE
1989-06-30
Composition 1 vaginal suppository contains: Active Ingredient Policresulen 90mg Excipients Macrogol 1500 and 4000; water Pharmaceutical form and contents Vaginal suppositories Packs with 6 vaginal suppositories Pharmacotherapeutic/ Indication group/action mechanism Antiseptic/ Gynaecological agent Manufacturer Takeda GmbH Robert-Bosch-Str. 8 78224 Singen Germany Marketing Authorization Holder Takeda Pharmaceuticals (Asia Pacific) Pte. Ltd 21 Biopolis Road Nucleos North Tower, Level 4 Singapore 138567 Indications Local treatment of inflammation or infection andtissue damage of vagina and cervix (e.g. dischargedue to bacterial, trichomonal and fungal infections,pressure sores from pessaries), condylomataacuminata, etc. Protuberance of cervical mucosa (cervical ectopia). Contraindications Albothyl vaginal suppositories must not be administeredin cases of hypersensitivity to any of theconstituents. Pregnancy and lactation Albothyl vaginal suppositories may be usedduring pregnancy and breastfeeding only whereit is strictly indicated, after due consideration ofthe risks to the mother and child. There havenot been any studies of the risks associated withuse during pregnancy in humans, but animal studieshave not yielded any evidence of fetal malformation.It is not known whether the active substancepasses into milk. Cauterization of the cervix should be avoided in pregnant women, particularly in the later stages of pregnancy, since it may cause labour to begin. The cervical portio and the parts of the vagina adjacent to the portio should be cauterized with appropriate care, and only in certain strictly defined indications. Special warnings and precautions for use - To avoid erosion of the oesophagus, care must be taken not to swallow the suppositories.If Albothyl vaginal suppositories havebeen swallowed inadvertently, Read the complete document
Composition 1 vaginal suppository contains: Active Ingredient Policresulen 90mg Excipients Macrogol 1500 and 4000; water Pharmaceutical form and contents Vaginal suppositories Packs with 6 vaginal suppositories Pharmacotherapeutic/ Indication group/action mechanism Antiseptic/ Gynaecological agent Manufacturer Takeda GmbH Robert-Bosch-Str. 8 78224 Singen Germany Marketing Authorization Holder Takeda Pharmaceuticals (Asia Pacific) Pte. Ltd 21 Biopolis Road Nucleos North Tower, Level 4 Singapore 138567 Indications Local treatment of inflammation or infection andtissue damage of vagina and cervix (e.g. dischargedue to bacterial, trichomonal and fungal infections,pressure sores from pessaries), condylomataacuminata, etc. Protuberance of cervical mucosa (cervical ectopia). Contraindications Albothyl vaginal suppositories must not be administeredin cases of hypersensitivity to any of theconstituents. Pregnancy and lactation Albothyl vaginal suppositories may be usedduring pregnancy and breastfeeding only whereit is strictly indicated, after due consideration ofthe risks to the mother and child. There havenot been any studies of the risks associated withuse during pregnancy in humans, but animal studieshave not yielded any evidence of fetal malformation.It is not known whether the active substancepasses into milk. Cauterization of the cervix should be avoided in pregnant women, particularly in the later stages of pregnancy, since it may cause labour to begin. The cervical portio and the parts of the vagina adjacent to the portio should be cauterized with appropriate care, and only in certain strictly defined indications. Special warnings and precautions for use - To avoid erosion of the oesophagus, care must be taken not to swallow the suppositories.If Albothyl vaginal suppositories havebeen swallowed inadvertently, Read the complete document